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Engineered biological systems hold promise in addressing pressing
human needs in chemical processing, energy production, materials
construction, and maintenance and enhancement of human health
and the environment. However, significant advancements in our
ability to engineer biological systems have been limited by the
foundational tools available for reporting on, responding to, and
controlling intracellular components in living systems. Portable
and scalable platforms are needed for the reliable construction of
such communication and control systems across diverse organisms.
We report an extensible RNA-based framework for engineering
ligand-controlled gene-regulatory systems, called ribozyme
switches, that exhibits tunable regulation, design modularity, and
target specificity. These switch platforms contain a sensor domain,
comprised of an aptamer sequence, and an actuator domain,
comprised of a hammerhead ribozyme sequence. We examined
two modes of standardized information transmission between
these domains and demonstrate a mechanism that allows for the
reliable and modular assembly of functioning synthetic RNA
switches and regulation of ribozyme activity in response to various
effectors. In addition to demonstrating examples of small
molecule-responsive, in vivo functional, allosteric hammerhead
ribozymes, this work describes a general approach for the con-
struction of portable and scalable gene-regulatory systems. We
demonstrate the versatility of the platform in implementing
application-specific control systems for small molecule-mediated
regulation of cell growth and noninvasive in vivo sensing of
metabolite production.
aptamer  regulatory systems  ribozyme  RNA switches 
synthetic biology
Basic and applied biological research and biotechnology arelimited by our ability to get information into and from living
systems and to act on information inside living systems (1–3). For
example, there are only a small number of inducible promoter
systems available to provide control over gene expression in re-
sponse to exogenousmolecules (4, 5).Many of themolecular inputs
to these systems are not ideal for broad implementation, because
they can be expensive and introduce undesired pleiotropic effects.
In addition, broadly applicable methods for getting information
from cells noninvasively have been limited to strategies that rely on
protein and promoter fusions to fluorescent proteins, which enable
researchers to monitor protein levels and localization and tran-
scriptional outputs of networks, leaving a significant amount of the
cellular information content currently inaccessible.
To address these challenges, scalable platforms are needed for
reporting on, responding to, and controlling any intracellular com-
ponent in a living system. A striking example of a biological
communication and control system is the class of RNA-regulatory
elements called riboswitches, comprised of distinct sensor and
actuation (gene-regulatory) functions, that control gene expression
in response to specific ligand concentrations (6). Building on these
natural examples, engineered riboswitch elements have been de-
veloped for use as synthetic ligand-controlled gene-regulatory
systems (7–10). However, these early examples of riboswitch engi-
neering do not address the challenges posed above because they
lack portability across organisms and systems, and their designs and
construction do not support modularity and component reuse.
We set out to develop a universal and extensible RNA-based
platform that will provide a framework for the reliable design and
construction of gene-regulatory systems that can control the ex-
pression of specific target genes in response to various effector
molecules.† We implemented five engineering design principles
(DPs) in addressing this challenge: DP1, scalability (a sensing
platform enabling de novo generation of ligand-binding elements
for implementation within the sensor domain); DP2, portability (a
regulatory element that is independent of cell-specificmachinery or
regulatory mechanisms for implementation within the actuator
domain); DP3, utility (a mechanism through which to modularly
couple the control system to functional level components); DP4,
composability (a mechanism by which to modularly couple the
actuator and sensor domains without disrupting the activities of
these individual elements); and DP5, reliability (a mechanism
through which to standardize the transmission of information from
the sensor domain to the actuator domain).
Results
Component Specification for a Scalable and Portable Gene-Regulatory
System. To satisfy the engineering DP of scalability, DP1, we chose
RNA aptamers (11), nucleic acid ligand-binding molecules, as the
sensing platform for the universal control system. Our choice of
sensing platform was driven by the proven versatility of RNA
aptamers. Standard in vitro selection strategies or systematic evo-
lution of ligands by exponential enrichment (SELEX) (12, 13) have
been used to generate RNA aptamers de novo to a wide variety of
ligands, including small molecules, peptides, and proteins (14). In
addition, the specificity and affinity of an aptamer can be tuned
through the selection process to meet the specific performance
requirements of a given application. The continued selection of new
aptamers to appropriate cellular molecules that function under in
vivo conditions will enable these elements to be implemented as
sensors in RNA-based control systems.
To satisfy the engineering DP of portability, DP2, we chose the
hammerhead ribozyme, a catalytic RNA, as the regulatory element
in the universal control system. Our choice of regulatory element
was driven by the ability of the hammerhead ribozyme to exhibit
self-cleavage activity across various organisms and its demonstrated
potential in biomedical and biotechnological applications owing to
its small size, relative ease of design, and rapid kinetics (15). The
utility of hammerhead ribozymes as gene-regulatory elements has
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been demonstrated in various systems (16–18). In addition, several
research groups have engineered a special class of synthetic ham-
merhead ribozymes referred to as allosteric hammerhead ri-
bozymes that contain separate catalytic and ligand-binding do-
mains, which interact in a ligand-dependent manner to control the
activity of the ribozyme (19–22). Although this class of ribozymes
enables a better control system because of the presence of the
integrated ligand-binding domain, there has been no success in
translating them to in vivo environments.
Design Strategies for Engineering Portability, Utility, and Compos-
ability into a Biological Control System. To support a framework for
engineering ligand-controlled gene-regulatory systems, we speci-
fied a design strategy that is in accordance with our engineering
DPs, stated above (Fig. 1). This strategy is comprised of three
components that address mechanisms for the portability, utility,
and composability (DP2–DP4, respectively) of the control system
and are critical to the development of a general ribozyme switch
platform. First, the cis-acting hammerhead ribozyme constructs are
integrated into the flexible regulatory space of the 3 UTR (Fig.
1A). We chose to locate the synthetic ribozymes within the 3UTR
of their target gene as opposed to the 5UTRto isolate their specific
cleavage effects on transcript levels from their nonspecific struc-
tural effects on translation initiation, because secondary structures
have been demonstrated to repress efficient translation when
placed in the 5 UTR (ref. 23 and K. Hawkins and C.D.S.,
unpublished observations). In addition, cleavage within the 3UTR
is a universal mechanism for transcript destabilization in eukaryotic
and prokaryotic organisms. Second, each ribozyme construct is
insulated from surrounding sequences, which may disrupt its struc-
ture and therefore its activity, by incorporating spacer sequences
immediately 5 and 3 of stem III (Fig. 1A). By implementing these
two components, we ensure that these control systems will be
portable across organisms and modular to coupling with different
coding regions (Y. Chen and C.D.S., unpublished work). The third
component was necessitated by the fact that previously engineered
in vitro allosteric ribozyme systems, which replace stem loops I or
II with part of the aptamer domain (Fig. 1B, lower right), do not
function in vivo. From previous studies on the satellite RNA of
tobacco ringspot virus (sTRSV) hammerhead ribozyme (17), we
suspect that this lack of in vivo functionality in earlier designs results
from removal of stem loop sequences that may play a critical role
in tertiary interactions that stabilize the catalytically active confor-
mation under physiological Mg2 concentrations. To develop ri-
bozyme switches that function in vivo, we chose to integrate the
hammerhead ribozyme into the target transcript through stem III
and couple the sensor domain directly to the ribozyme through
stem loops I or II to maintain these potentially essential sequence
elements (Fig. 1B, upper right). Construction and characterization
of the regulatory activity of a series of ribozyme control constructs
in the eukaryotic model organism Saccharomyces cerevisiae (Fig.
1A) indicate that maintenance of loop I and II sequences and thus
integration through stem III are essential for their in vivo function-
ality (SI Text and SI Fig. 7).
Engineering Mechanisms for Information Transmission Between the
Modular Switch Domains. The final design challenge in building a
universal switch platform is to develop a standardized means of
transmitting information (encoded within an information transmis-
sion domain) from the sensor (aptamer) domain to the regulatory
(ribozyme) domain (i.e., DP5). There are two different strategies
for transmitting information between the aptamer and ribozyme
domains: strand displacement and helix slipping. We constructed
and characterized ribozyme switch platforms based on both
mechanisms.
The first information transmission domain that we developed is
based on a strand-displacement mechanism, which involves the
rational design of two sequences that compete for binding to a
general transmission region (the base stem of the aptamer) (Fig. 2
A and B). We used this mechanism in engineering a ribozyme
switch platform that enables both up- and down-regulation of gene
expression in response to increasing effector concentrations (‘‘ON’’
and ‘‘OFF’’ switches, respectively). An initial ribozyme switch,
L2bulge1, was constructed to up-regulate gene expression through
the corresponding base platform, L2Theo (SI Fig. 7C), by incor-
porating a competing strand following the 3 endof the theophylline
aptamer (24) (Fig. 2A). This competing strand is perfectly com-
plementary to the base stem of the aptamer at the 5 end. Using the
same DPs, we engineered another ribozyme switch, L2bulgeOff1
(Fig. 2B), for down-regulating gene expression. Our strand dis-
placement strategy is based on the conformational dynamics char-
acteristic of RNA molecules that enables them to distribute be-
tween at least two different conformations at equilibrium: one
conformation in which the competing strand is not base-paired or
is base-paired such that the ligand-binding pocket is not formed,
and the other conformation in which the competing strand is
base-paired with the aptamer base stem, displacing the switching
strand and thus allowing the formation of the ligand-binding
pocket. Strand displacement results in the disruption (L2bulge1) or
restoration (L2bulgeOff1) of the ribozyme’s catalytic core. Binding
of theophylline to the latter conformation shifts the equilibrium
distribution to favor the aptamer-bound form as a function of
increasing theophylline concentration. An 25-fold increase in
target expression levels at 5 mM theophylline, relative to those in
the absence of effector, was observed in L2bulge1 (Fig. 2C and SI
Fig. 8). In contrast, an 18-fold reduction in expression levels at 5
mM theophylline, relative to those in the absence of effector, was
observed in L2bulgeOff1 (Fig. 2D and SI Fig. 8). Through our
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strand-displacement mechanism, we have engineered ribozyme
switches de novo that provide allosteric regulation of gene expres-
sion and function as ON and OFF switches.
We engineered a second ribozyme switch platform to examine an
alternative information transmission domain based on a helix-
slipping mechanism, which does not allow for rational design (Fig.
3A). This mechanism involves the functional screening of ‘‘com-
munication modules’’ (20–22) within the base stem of the aptamer.
Communication modules are dynamic elements capable of trans-
mitting the binding state of an aptamer domain to an adjacent
regulatory domain through a ‘‘slip-structure’’ mechanism (20), in
which a nucleotide shift event is translated to a small-scale change
in the conformation of the regulatory domain in a ligand-dependent
manner. These elements have been developed through in vitro
screening processes, and their communicative properties have been
demonstrated in vitro in engineered allosteric ribozymes (19–22).
We screened the in vivo functionality of previously in vitro selected
communication modules (20–22) by assaying the activity of these
sequences within L1Theo and L2Theo. A critical difference be-
tween the design of the previously developed in vitro allosteric
ribozymes, from which these communication modules were gen-
erated, and that of our engineered ribozyme switches is the coupling
strategies between the aptamer and ribozyme domains and their
effects on the in vivo activity of the ribozyme domain as described
previously (Fig. 1B). Among the 13 communication modules (20–
22) screened for in vivo activity, five (cm1, cm4, cm5, cm9, and cmd)
exhibit down-regulation of expression levels through loop II,
whereas only two (cm10 and cmd) exhibit such regulation through
loop I (Fig. 3B and SI Fig. 9). The regulatory activities of two
helix-slipping-based ribozyme switches, L2cm4 andL1cm10 (SI Fig.
10), were characterized across a range of theophylline concentra-
tions and exhibit substantial regulatory effects. Although the helix-
slipping constructs are comprised of identical aptamer and catalytic
core sequences, they exhibit different extents of regulation. This
variability suggests that each construct contains a different equi-
librium distribution between the adoptable conformations and that
the energy required for structural switching between the confor-
mations is also different.
We validated the regulatory mechanisms of representative
strand-displacement- and helix-slipping-based switches. Relative
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steady-state transcript levels in the absence and presence of effector
are consistent with corresponding fluorescent protein levels (SI
Table 1), indicating that cleavage in the 3 UTR results in rapid
decay and inactivation of the target transcript. In addition, we
demonstrated that changes in expression levels are induced shortly
after effector addition (SI Fig. 11), indicating that the response of
the regulatory elements to changes in effector levels is relatively
rapid.
Rational Tuning Strategies Enable Programming of Switch-Regulatory
Response. The ability to program the regulatory response of a
universal switch platform is an important property in tuning the
platform performance to comply with the design specifications for
a particular application. We demonstrate that our strand-
displacement-based switch platform incorporates an information
transmission mechanism that is amenable to rational tuning strat-
egies for programming response properties. Programming of new
regulatory information is achieved by sequence alteration, resulting
in a change in the molecule’s structural stability, which may affect
its switching dynamics if the molecule can adopt multiple confor-
mations. These rational sequencemodification tuning strategies are
not applicable to communicationmodule-based switches because of
an inability to predict their activities. A more complete description
of our tuning strategies is provided in SI Text, SI Fig. 12, and SI
Table 2. Briefly, our rational tuning strategies target alteration of
the nucleotide composition of the base stem of the aptamer domain
to affect the stabilities of individual constructs and the energies
required for the construct to switch between two adoptable con-
formations. Using these strategies, we rationally engineered a series
of tuned ON and OFF switches from L2bulge1 and L2bulgeOff1,
respectively (Fig. 4A). These tuned switches exhibit different reg-
ulatory ranges in accordance with our rational energetic tuning
strategies (Fig. 4 B and C and SI Figs. 13 and 14).
The Ribozyme Switch Platform Exhibits Component Modularity and
Specificity. In implementing a standardized mechanism through
which to transmit information between the domains of a switch
platform (DP5), we needed to confirm that the modular coupling
between the aptamer and ribozyme domains is maintained (DP4).
We performed modularity studies on our strand-displacement-
based ribozyme switch platform, in which aptamers possessing
sequence flexibility in their base stems can be swapped into the
sensor domain. To begin to demonstrate that ribozyme switch
activity may be controlled by different effector molecules, we
replaced the theophylline aptamer of L2bulge1 with a tetracycline
miniaptamer (25) to construct a tetracycline-responsive ON switch
(L2bulge1tc) (Fig. 5A). Despite similar aptamer ligand affinities
(24, 25), the extent of up-regulation with L2bulge1tc was greater
than that with L2bulge1 at the same extracellular concentration of
their respective ligands (Fig. 5B). This is likely because of the high
cell permeability of tetracycline (26) compared with theophylline
(27). These results demonstrate that our strand-displacement-based
switch platform maintains modularity between the aptamer and
ribozyme domains. We also performed similar modularity studies
on the helix-slipping-based switch platform by replacing the the-
ophylline aptamer of L1cm10, L2cm4, and L2cm5 with the tetra-
cycline miniaptamer (L1cm10tc, L2cm4tc, and L2cm5tc, respec-
tively). These constructs do not exhibit effector-mediated gene-
regulatory effects (data not shown).We also demonstrated that the
aptamer sequences (theophylline and tetracycline) incorporated
into our ribozyme switch platforms maintain highly specific target
recognition capabilities in vivo, similar to their in vitro specificities
generated during the selection process against corresponding mo-
lecular analogues (caffeine and doxycycline, respectively) (24, 25)
(Fig. 5B). This is an important property in implementing these
platforms in cellular engineering applications that involve complex
environments where molecular species similar to the target ligand
may be present.
Component Modularity Enables Implementation of Ribozyme
Switches as Regulatory Systems in Diverse Applications. To demon-
strate the scalability and utility of these switch platforms as appli-
cation-specific control systems, we demonstrate the implementa-
tion of ribozyme switches in two distinct cellular engineering
application areas. First, utility (DP3) and the ability to respond to
and control cellular information are demonstrated by the applica-
tion of ribozyme switches to small molecule-mediated regulation of
cell growth. Second, scalability (DP1) and the ability to respond to
and report on cellular information are demonstrated by the imple-
mentation of ribozyme switches as noninvasive in vivo sensors of
metabolite production.
The first system explores the application of our ribozyme
switches to the regulation of a survival gene, where modification of
expression levels is expected to produce an observable and titrat-
able phenotypic effect on cell growth. The reporter gene within the
original constructs was replaced with a growth-associated gene,
his5, responsible for the biosynthesis of histidine in yeast (28) (Fig.
6A). We performed growth-regulation assays across various effec-
tor concentrations using representative switch constructs and dem-
onstrated that these switches mediate cell growth in a highly
effector-dependent manner (Fig. 6B and SI Fig. 15). This applica-
tion demonstrates the utility (DP3) of our switch platform, in which
the control system exhibits modularity to the functional level
components in the regulatory system.
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The second system explores the application of these ribozyme
switches to the in vivo sensing of metabolite production to dem-
onstrate that these switches provide a noninvasive mechanism
through which to transmit molecular information from cells. Nu-
cleoside phosphorylase activities resulting inN-riboside cleavage of
purine nucleosides have been identified in various organisms (29).
We observed that feeding xanthosine to our yeast cultures results
in the production of xanthine, a product synthesized through
riboside cleavage of xanthosine. The theophylline aptamer used in
our switch platforms possesses a reduced binding affinity for
xanthine (27-fold lower than theophylline) (24). We used two ON
switch constructs (L2bulge1 and L2bulge9) for the in vivo detection
of xanthine production in cultures fed xanthosine (Fig. 6C). GFP
levels in cells fed xanthosine rose steadily between 24 and 40 h after
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feeding in correlation with HPLC data (Fig. 6D and SI Fig. 16),
illustrating the noninvasive metabolite-sensing capabilities of these
switches through transmitting changes in metabolite accumulation
to changes in reporter expression levels. This application demon-
strates the scalability (DP1) of our switch platform, in which the
unique properties of the sensing platform used in this control
system enable broad implementation in diverse applications not
generally accessible by other regulatory systems.
Discussion
Akey component in the development of anRNA-based framework
for engineering ligand-controlled gene-regulatory systems is cap-
tured within DP5: a mechanism through which to reliably transmit
information between distinct domains of the molecule. The strand-
displacement and helix-slipping mechanisms demonstrate different
strengths and weaknesses as standardized means of transmitting
information from the aptamer domain to the ribozyme domain.
Only 7 of the 26 tested communication modules exhibited regula-
tory activity in our system. In addition, all of the functional
communication module sequences demonstrated OFF activity in
our in vivo system, whereas one of these sequences (cmd) exhibited
ON activity in an in vitro system (20). These results indicate that in
vitro functionality of these elements is selectively translated to in
vivo activity due to their sensitivity to surrounding sequences.
Furthermore, modularity studies performed on this platform indi-
cate that the helix-slipping mechanism is not amenable to modular
domain-swapping strategies. In contrast, we have demonstrated
that strand displacement exhibits greater reliability as an informa-
tion transmission mechanism in our platform and is characterized
by engineering properties such as modular assembly, rational de
novo design, flexible induction and repression profiles, and re-
sponse programmability. Although not preferred for the rational
design strategies presented here, our helix-slipping platform can be
used for the effective generation of new ribozyme switches by in vivo
screening for helix-slipping elements that function with new
aptamer sequences, different regulatory ranges, and flexible reg-
ulatory profiles. In addition, screening strategies may represent a
powerful alternative when rational design strategies fail. For exam-
ple, we were unable to successfully apply our rational design
strategies to the construction of strand-displacement-based ri-
bozyme switches thatmodulate cleavage through stem I (L1bulge1–
L1bulge6 in SI Table 3). These results indicate that screening
strategies may be more effective in generating switches that mod-
ulate activity through stem I.
We have developed and demonstrated universal RNA-based
regulatory platforms called ribozyme switches by using engineering
DPs. This work describes a framework for the reliable de novo
construction ofmodular, portable, and scalable control systems that
can be used to achieve flexible regulatory properties, such as up-
and down-regulation of target expression levels and tuning of
regulatory response to fit application-specific performance require-
ments, thereby expanding the utility of our platforms to a broader
range of applications. For example, these switch platforms may be
applied to the construction of transgenic regulatory control systems
that are responsive to cell-permeable, exogenous molecules of
interest for a given network. In regulating sets of functional
proteins, these switches can act to rewire information flow through
cellular networks and reprogram cellular behavior in response to
changes in the cellular environment. In regulating reporter proteins,
ribozyme switches can serve as synthetic cellular sensors tomonitor
temporal and spatial fluctuations in the levels of diverse input
molecules. The switch platforms described here represent powerful
tools for constructing ligand-controlled gene-regulatory systems
tailored to respond to specific effector molecules and enable
regulation of target genes in various living systems; due to their
general applicability, our platforms offer broad utility for applica-
tions in synthetic biology, biotechnology, and health and medicine.
Materials and Methods
Plasmid and Switch Construction. By using standard molecular
biology techniques (30), a characterization plasmid, pRzS, harbor-
ing the yeast-enhanced GFP (yEGFP) (31) under control of a
GAL1-10 promoter, was constructed. For the ribozyme switch-
mediated growth studies, the yegfp gene was replaced with the his5
gene (28). See SI Text for details.
RNA Secondary Structure Prediction and Free Energy Calculation.
RNAstructure 4.2 (http://rna.urmc.rochester.edu/rnastructure.
html) was used to predict the secondary structures of all switch
constructs and their thermodynamic properties. RNA sequences
that are predicted to adopt at least two stable equilibrium confor-
mations (ribozyme-inactive and -active) were constructed and
examined for functional activity.
Ribozyme Characterization, Cell Growth Regulation, and Metabolite
Sensing Assays. See SI Text for details. Briefly, cells harboring
appropriate plasmids were grown in the absence or presence of
corresponding ligands or substrates and characterized for ligand-
regulated ribozyme switch activity, cell growth, and metabolite
sensing.
Fluorescence Quantification and Quantification of Cellular Transcript
Levels. See SI Text for details. Briefly, total RNA was extracted by
employing standard acid phenol methods (32) followed by cDNA
synthesis and PCR amplification.
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